Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm.
about
The biochemical and mass spectrometric profiling of the dystrophin complexome from skeletal muscleProteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathyApplication of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy researchProteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.Pathoproteomics of testicular tissue deficient in the GARP component VPS54: the wobbler mouse model of globozoospermia.Skeletal muscle proteomics: current approaches, technical challenges and emerging techniquesSimultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular DystrophyIdentification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.Profiling of age-related changes in the tibialis anterior muscle proteome of the mdx mouse model of dystrophinopathyProteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophyIdentification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophyConcurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.Proteomics of skeletal muscle differentiation, neuromuscular disorders and fiber aging.Proteomic identification of biomarkers of skeletal muscle disorders.Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.Chaperoning heat shock proteins: proteomic analysis and relevance for normal and dystrophin-deficient muscle.Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation.Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis.Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.Accurate quantification of dystrophin mRNA and exon skipping levels in duchenne muscular dystrophy.Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophyProteomic assessment of the acute phase of dystrophin deficiency in mdx mice.Comparative 3-Sample DIGE Analysis of Skeletal Muscles.DIGE Analysis Software and Protein Identification Approaches.Comparative DIGE Proteomics.Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy.Proteomic profiling of muscle fibre type shifting in neuromuscular diseases.Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers.Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies
P2860
Q26770343-A5662C74-0F0E-4223-9EBE-62CF6DE8C230Q27006945-8EACCE93-A25E-4F3C-8A17-6458E51E194DQ33565229-D9A601DB-6304-40E7-9D71-F5AE6D056E88Q33871052-45E38A31-E10D-4494-B557-5FEC68546DDAQ33930110-42382A5B-5CB5-405C-8988-D40F2FE403C5Q34376937-6C758A8E-9511-47D2-A5C1-ACBED79F5656Q35128702-400A088E-9A0C-4940-94D0-7D8008EA8559Q35837856-9AA03BCD-728D-4F98-A3F4-5AA01A5C25C7Q36015171-2E702A66-2A41-4D71-BC0D-2B8657271B25Q36316393-9D22760F-5DDF-414C-932D-AECE337FA259Q36613670-5D245556-2691-4175-A44E-13148622781EQ36832437-7225285E-9544-4B1E-B0D4-4B5B2382D1FCQ37196136-614A85BA-7AA5-4A78-B05F-FF8896D4455EQ37566483-925CE909-601C-4230-A271-D84F450974D7Q37727204-0F301601-401D-4F4C-B76E-EE5C271BDBEFQ38079622-6ABA5D80-7BA7-4E9C-AD8B-783E9B9570CBQ38115148-62612E0E-CD1A-40EA-82E8-44388304E939Q38217473-6AB1F6EC-6FFD-47BA-B5AA-67F1740F7AFEQ38563300-628B7A78-891D-4E6F-A341-6244DAF1A984Q38850056-8D367F66-9675-4D77-A1E0-8B7EB640C2DDQ39033229-821AE71A-A2C8-4A5B-8A94-436B0CC2E001Q39205845-D868EDFD-D2AA-4CF9-9717-57176BE683C6Q39932620-05C56D31-936E-489B-A277-2A125EED49D7Q42587467-AE990840-1B15-4B97-B47B-A2D67F587007Q43884201-44CC2863-CD47-4108-AEDA-F4D6EFAE5D32Q46289186-88DD8340-5C35-4168-9123-F26DFA11AB7DQ47668016-D6F051F5-721B-459B-B196-956F054FB25CQ47668027-2D738C27-1681-4469-9665-3263D237C3E5Q50019659-21B52F4E-76C3-45E9-B3A8-ABB9BF08669FQ51664676-D0FC8AC6-1EDA-4E35-A82C-E67BB539E74CQ53457776-C60C3228-3AF6-49E9-A248-3CE38DBDE624Q57831005-766ED9A8-0BF1-4583-A463-7DA9A9C6A22C
P2860
Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Proteomic profiling of antisen ...... s in dystrophic mdx diaphragm.
@ast
Proteomic profiling of antisen ...... s in dystrophic mdx diaphragm.
@en
type
label
Proteomic profiling of antisen ...... s in dystrophic mdx diaphragm.
@ast
Proteomic profiling of antisen ...... s in dystrophic mdx diaphragm.
@en
prefLabel
Proteomic profiling of antisen ...... s in dystrophic mdx diaphragm.
@ast
Proteomic profiling of antisen ...... s in dystrophic mdx diaphragm.
@en
P2860
P356
P1433
P1476
Proteomic profiling of antisen ...... es in dystrophic mdx diaphragm
@en
P2093
Philip Doran
Steve D Wilton
P2860
P304
P356
10.1002/PMIC.200800441
P577
2009-02-01T00:00:00Z